ENvue Medical, Inc. (FEED)
NASDAQ: FEED · Real-Time Price · USD
4.050
+0.030 (0.75%)
Dec 12, 2025, 2:05 PM EST - Market open
ENvue Medical Revenue
ENvue Medical had revenue of $722.00K in the quarter ending September 30, 2025, with 92.02% growth. This brings the company's revenue in the last twelve months to $2.69M, down -18.41% year-over-year. In the year 2024, ENvue Medical had annual revenue of $2.56M with 12.05% growth.
Revenue (ttm)
$2.69M
Revenue Growth
-18.41%
P/S Ratio
0.26
Revenue / Employee
$86,613
Employees
31
Market Cap
4.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.56M | 275.00K | 12.05% |
| Dec 31, 2023 | 2.28M | 1.53M | 203.59% |
| Dec 31, 2022 | 752.00K | -943.00K | -55.63% |
| Dec 31, 2021 | 1.70M | 1.07M | 172.07% |
| Dec 31, 2020 | 623.00K | 93.00K | 17.55% |
| Dec 31, 2019 | 530.00K | 212.00K | 66.67% |
| Dec 31, 2018 | 318.00K | 79.00K | 33.05% |
| Dec 31, 2017 | 239.00K | 10.00K | 4.37% |
| Dec 31, 2016 | 229.00K | 82.00K | 55.78% |
| Dec 31, 2015 | 147.00K | -56.00K | -27.59% |
| Dec 31, 2014 | 203.00K | -8.00K | -3.79% |
| Dec 31, 2013 | 211.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walmart | 703.06B |
| Amazon.com | 691.33B |
| Apple | 416.16B |
| Alphabet | 385.48B |
| Berkshire Hathaway | 372.13B |
| Microsoft | 293.81B |
| Meta Platforms | 189.46B |
| NVIDIA | 187.14B |
FEED News
- 6 hours ago - NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED' - Business Wire
- 23 days ago - NanoVibronix Issues Letter to Shareholders - Business Wire
- 3 months ago - NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities - Business Wire
- 3 months ago - NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 3 months ago - NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio - Business Wire
- 3 months ago - NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology - Business Wire
- 4 months ago - NanoVibronix Announces Reverse Stock Split - Business Wire
- 5 months ago - NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock - Business Wire